key: cord-0850958-s112o94i authors: Sahu, Jitendra Kumar; Madaan, Priyanka; Chand, Prem; Kumar, Amit; Linn, Kyaw; Mynak, Mimi Lhamu; Poude, Prakash; Wanigasinghe, Jithangi title: Management of West syndrome during COVID-19 pandemic: A viewpoint from South Asian West Syndrome Research Group date: 2020-08-31 journal: Epilepsy Res DOI: 10.1016/j.eplepsyres.2020.106453 sha: 801ae002a30292e5e7495734dc1ab7ef5c76dcd2 doc_id: 850958 cord_uid: s112o94i In the wake of the pandemic COVID-19 and nationwide lockdowns gripping many countries globally, the national healthcare systems are either overwhelmed or preparing to combat this pandemic. Despite all the containment measures in place, experts opine that this novel coronavirus is here to stay as a pandemic or an endemic. Hence, it is apt to be prepared for the confrontation and its aftermath. From protecting the vulnerable individuals to providing quality care for all health conditions and maintaining essential drug supplies, it is going to be a grueling voyage. Preparedness to sustain optimal care for each health condition is a must. With a higher risk for severe COVID-19 disease in infants, need of high-dose hormonal therapy with a concern of consequent severe disease, presence of comorbidities, and a need for frequent investigations and follow-up; children with West syndrome constitute a distinctive group with special concerns. In this viewpoint, we discuss the important issues and concerns related to the management of West syndrome during COVID-19 pandemic in the South Asian context and provide potential solutions to these concerns based on the current evidence, adeptness, and consensus. Some plausible solutions include the continuation of containment and mitigation measures for COVID-19, therapeutic decision- making for West syndrome based on risk stratification, and tele-epileptology. The Coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a global health concern. In a systematic review, children accounted for 1-5% of diagnosed cases. 1 Although most children and infants remain asymptomatic or mildly affected, the prevalence of the severe and critical disease in infancy is to the tune of 10%. 1 Besides COVID-19, the nationwide lockdowns and diversion of resources have significantly impacted the care of patients with other medical conditions. In developing countries with a relatively low doctor-patient ratio, this might lead to a delay in seeking medical attention due to constraints of funds, halted transport facilities, fear of SARS-CoV-2 infection, poor awareness, etc. Other J o u r n a l P r e -p r o o f nuances such as unavailability of imported drugs, a standstill of regular clinic activities and rehabilitation services, etc. may be additive. Preparedness to sustain optimal care for each health condition is a must. In this context, West syndrome (WS) being the commonest epileptic encephalopathy constitutes a distinctive condition considering the higher risk of severe COVID-19 disease in infants, peculiar management options [high-dose hormonal therapy (oral steroids and adrenocorticotrophic hormone; ACTH) and vigabatrin], need for frequent follow-up, and dependence of therapeutic response on treatment lag. 2 However, there would be applicability concerns for South Asia and developing countries due to peculiar management practices and challenges for WS. A preponderance of structural etiology, long treatment lag, difficult access to EEG, availability and licensing issues with the first-line drugs (ACTH and vigabatrin), and underdeveloped telehealth services make this region eccentric. 5, 6 Although the fundamental management principles are analogous, the widespread applicability of CNS recommendations may be dubious. While our knowledge is still evolving, preparedness is essential by pediatric neurologists. Hence, this paper focuses on providing answers to potentially important issues in the management of WS during COVID-19 pandemic in South Asian context based on current evidence, expertise, experience, and consensus. South Asian West Syndrome Research Group (SAWSRG) was formed in early 2019, while studying the management practices for WS in South Asia. 5 The members of the SAWSRG identified the key issues concerning COVID-19 with WS. A detailed literature search was performed using the electronic databases PubMed/Medline, Google Scholar, Web of Science, Website content of World health Organization and ILAE from December 2019 to May 15, 2020, with "COVID-19" OR "2019-nCovid" AND "infantile spasms" OR "West syndrome" as search terms. Subsequently, an interactive online meeting and multiple correspondences were held among the group members to formulate the viewpoint, and a consensus was obtained on issues with uncertainty. Literature review was subsequently updated till July 19, 2020. Although an initial outpatient EEG confirmation of hypsarrhythmia and subsequent 2- week follow-up EEG to demonstrate therapeutic response, as recommended by the CNS, are desirable, the decision may be individualized based on the feasibility and access of pediatric EEG services. In concurrence with the CNS recommendations, outpatient EEG should be preferred including at least one sleep-wake cycle. 4 Efforts should be made to ensure wider availability of pediatric EEG facilities in South Asia. There is a concern about the possibility of Jithangi Wanigasinghe contributed by participating as an expert and by critical review of the manuscript for intellectual content. All authors approved the final version of the manuscript to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Dr. Jitendra Kumar Sahu serves as a section editor for Indian Journal of Pediatrics and received extramural research grant from Indian Council of Medical Research for "West syndrome-EAST" trial. However, no disclosure pertaining to the study. Rest of the authors have no conflict of interest to disclose with regard to this article. J o u r n a l P r e -p r o o f We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study Care delivery for children with epilepsy during the COVID-19 pandemic: an international survey of clinicians Management of Infantile Spasms During the COVID-19 Pandemic Management practices for West syndrome in South Asia: a survey study and meta-analysis Attitude and Practice (KAP) Study of Pediatricians on Infantile Spasms Mortality in infantilespasms: A hospital-based study New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study Genetic epilepsies and COVID-19 pandemic: Lessons from the caregiver perspective Pyretotherapy as treatment in West's syndrome Spontaneous remission of infantile spasms and hypsarrhythmia following acute infection with high-grade fever How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review The severity of COVID-19 in children on immunosuppressive medication COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2 None